One of the congress chairs of this year's EAS Congress is Erik Stroes, who is no stranger to Resverlogix and apabetalone. He's given talks at the recent ESC 2018 and ERA-EDTA 2018 symposiums focusing on the potential of epigenetics and apabetalone. 

https://pace-cme.org/2018/08/28/ldl-c-done-deal-next-epigenetics/

https://pace-cme.org/2018/05/25/epigenetics-in-ckd-cvd-a-potential-breakthrough-therapy/